China SXT Pharmaceuticals-ASXTC
13F holders, Q1 2025 (March 31)2holders
$2.47avg. 13F price*
At the end of Q1 2025, 2 institutions reported holding China SXT Pharmaceuticals-A (SXTC) in their 13F filings. The largest holders were UBS Group AG ($13K) and Acadian Asset Management LLC ($0).
- Company
- China SXT Pharmaceuticals-A
- CUSIP
- G2161P157
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $13K |
| Exits | 0 | $0 |
Ownership 2 holders
| UBS Group AG | 0.00% | New | 5,270 | $13K |
| Acadian Asset Management LLC | 0.00% | New | 48 | $0 |
"% of holder's portfolio" is SXTC's weight in each manager's 13F, not the share of China SXT Pharmaceuticals-A the manager owns.